中文
| Catalogue |
| Recommend Products |
Company News
- AMSBIO: Optimized Medium for Expansion of Mesenchymal Stem Cells 9/18/2020
- AMSBIO: Optimized Freezing Solutions for Clinical Application of Cell Therapy Products 9/2/2020
- AMSBIO: New Cytometry Service Provides Automated Analysis of Fluorescent Biomarkers 8/21/2020
- AMSBIO: Tailored Solutions for Exosome-related Research 7/28/2020
- AMSBIO: Differentiation of Human iPS and ES Cells 7/17/2020
- AMSBIO Launched New Range of SARS-CoV-2 Spike Protein Products 6/18/2020
- AMSBIO: Investigating the Role of Heparins in Combating Covid-19 Infection 6/9/2020
- AMSBIO: High-Throughput Screening Using Luciferase Reporter Cell Lines 5/19/2020
- AMSBIO: Identifying Targets for Development of COVID-19 Drugs & Vaccines 5/8/2020
- AMSBIO: Eliminate Viruses & Other Pathogens with Ease 4/21/2020
- AMSBIO: Total Nucleic Acid Extraction for Pathogen Detection 4/8/2020
- AMSBIO: Clinical Study of iPSC-derived Corneal Epithelial Cells 4/1/2020
- AMSBIO Launch Coronavirus – COVID-19 Research Products 3/17/2020
- AMSBIO: Generation of Muscle Cells in 3 Easy Steps 3/3/2020
- AMSBIO: Easy Isolation of PBMCs from Whole Blood 2/18/2020
- AMSBIO: Custom CAR-T Development Service 1/30/2020
- AMSBIO: Hyaluronic Acid Degeneration in Invertebral Disc Health 1/22/2020
- AMSBIO: Efficient Isolation of Circulating Cell Free DNA 12/19/2019
- AMSBIO: 3D Cell Culture Proves Invaluable to Myelination Research 12/10/2019
- AMSBIO: ELRIG Recognize ScreenIn3D's Technical Innovation 11/29/2019